Opexa Therapeutics, Inc. (OPXA)

[redspinelpinktopaz]

We're following Neil in an unmarked car to see where he's going to sell the company to someone.

[Moto260]

Where is everyone.

[ClayTrader]

* * $OPXA Video Chart 12-22-16 * *

Link to Video - click here to watch the technical chart video

[UP Trend]

Good timing, back over a dollar!

[G3TCRUNK3R]

I'm back in at .90
Would like to see my previous stop loss set at 1.20 :)

[UP Trend]

All going except this one, needs some volume.

[UP Trend]

Agree, yesterday was reload day.

[Lone Wolf]

Bio-techs gonna be strong today! Just sayin'!!

$OPXA

[G3TCRUNK3R]

Whew. I'm really happy I was able to get out at 1.20 on Friday.

[ClayTrader]

* * $OPXA Video Chart 12-09-16 * *

Link to Video - click here to watch the technical chart video

[G3TCRUNK3R]

I switched last second today, out at 1.20. hope for no share offering for everyone involved.

[G3TCRUNK3R]

DO I DARE HOLD THIS OVER THE WEEKEND, OR SWITCH AT THE LAST MINUTE TO JNUG? I HAVE 30 MINUTES TO MAKE UP MY MIND.

[UP Trend]

Wishful thinking, they were saying same about idxg and look at them now.. Shorts see the 150 break happening and screaming offering to try and get shares to cover with. 8 million volume says it all.

[harmsen]

Offering?

[UP Trend]

Triple normal volume! Can we say squeeze please:)

[davidsson10]

Seeking Alpha:

Opexa up almost 50%, equity offering coming?

Nano cap Opexa Therapeutics (OPXA +47.7%) jumps on more than triple normal volume. Shares are up 160% since bottoming at $0.50 on November 9 after the Tcelna flop in a multiple sclerosis study.
No particular news accounts for the action, but the company stated in a November 14 press release that its quick assets will only be sufficient to fund operations into Q1. An equity offering could be announced any time.

[UP Trend]

Beasting! Hold tight!!

[UP Trend]

Back to last month highs! Let's keep squeezing this gem!!

[Warchest]

big boys ready to slap !!

[UP Trend]

Looking primed! Moving!

[UP Trend]

Next pharma to run perhaps!

[Warchest]

on the run !!! $$$$

[FutureCEO]

2200 @ 1.11 just filled

[Ken666]

Stem cell therapy. Is congress about to pass a bill to pump money into technology? http://www.huffingtonpost.com/entry/congress-21st-century-cures_us_583e3d98e4b0ae0e7cdaca32

[Ken666]

Reforms coming to the drug companies. http://tinyurl.com/hmr7vhe

Of course a cheap stock like this could go up a great deal if their drug can escape the insane regulations currently over their head.

[bogblog]

Very interesting. I'd be interested to hear more... who are these 'Sose bandits'?

[redspinelpinktopaz]

It was purely OTC. We were market makers, each
trading 30-60 stocks, trying to be flat when the
market closed. We acted as 'principal'. Our customers
were the brokerage houses. They could act as
'principal' also, marking up the stock. Or they
could charge a commission and act as 'agent'
We were way to busy to play games with rigging a
stock. And we might--probably would--get fired
if we did such a thing. But we're talking sixties
and seventies, when there were only a handful of
hedge funds. Everything was a lot cleaner then.
The "Sose Bandits" changed all that and the spreads
became miniscule.

[bogblog]

Well to be honest, I'm just in this for the chart, and plan to sell next week. I like the fundamentals here, but I don't have the money to be an investor. I do this for a living with a small account subject to PDT, so I've got to trade aggressively and book profits as they come.

Wow, so you used to be a market maker -- can I ask you a question or two? Did you trade on the OTCs too? The OTCs are my bread and butter. I hear a lot of stories about MM manipulation on the OTCs, with things like naked shorting, and using codes to communicate with other MMs, for example, on a penny stock, using a 100 share order to mean 'I need shares' or 300 share order for 'lets trade this sideways for a while' and so on.

On the other hand... I've heard people say that MMs can only execute orders given to them by clients, and that 'MM manipulation' is all a load of conspiracy BS.

As you were a market maker, if you could share your thoughts on some of these issues, I would be fascinated to hear them.

Do you have market markers who you look for when in a trade? I know to run when I see VNDM, because he tends to sell with no regard for share price. But he's the only MM I have a strong opinion about.

[redspinelpinktopaz]

You may be right about market makers playing games--I was a market maker and I played games--but if T-cells are part of the future of medicine, and I asked a young, very smart, radiation oncologist at Thanksgiving dinner, yesterday, if T-cell therapy would work, and he said, "Absolutely!", Opexa has a boatload of knowledge, so as the old cliché goes: "stay tuned."
"

[bogblog]

I'm new to OPXA but my reading of the news is that it's basically non-news at this point. So these Merck guys didn't want to buy OPXA's thing that failed in late October. That seems pretty obvious. So my take on the news is just confirmation of what was already expected. Any other takes on our pre-market news? OPXA hitting 1.02 after-hours, making me a little concerned as I'm long at 1.12. I'm thinking just MMs playing games.

[Ken666]

https://marketexclusive.com/opexa-therapeutics-inc-nasdaqopxa-files-an-8-k-termination-of-a-material-definitive-agreement/40918/

[Ken666]

Termination of a Material Definitive Agreement.

Opexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company. The Company is engaged in the development of a personalized immunotherapy with the potential to treat various illnesses, including multiple sclerosis (MS), as well as other autoimmune diseases, such as neuromyelitis optica (NMO). These therapies are based on its T-cell technology. The Company’s product candidates include Tcelna and OPX-212. Tcelna is an autologous T-cell immunotherapy that is being developed for the treatment of secondary progressive MS (SPMS) and is tailored to each patient’s immune response profile to myelin. Tcelna is designed to reduce the number and/or functional activity of specific subsets of myelin-reactive T-cells (MRTCs) known to attack myelin. Tcelna is manufactured using its method for the production of an autologous T-cell product. In addition to the ongoing clinical development of Tcelna, the Company is developing OPX-212 as an autologous T-cell immunotherapy for the treatment of NMO.

[redspinelpinktopaz]

That's before Tcelna went to Hellna!

[Ken666]

Opexa Therapeutics, Inc. (NASDAQ:OPXA) stock is presently standing at about $1.05 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 3 analysts covering the company is $11.00, which suggests the stock could still rise over 90 percent.
http://theindependentrepublic.com/2016/11/23/what-wall-street-is-saying-about-opexa-therapeutics-inc-nasdaqopxa/

[redspinelpinktopaz]

Certainly no surprise. So now we'll see what
the 160 patents and T-cell technology is
worth. Neil K Warma is a business man.
We'll soon see how good he is. Go get
em, Neil!.

[Prinz18]

News...

[beambe]

better $.50

[Prinz18]

When to buy again? $.70 or $.50? Or even lower?

[Moto260]

Dang should have held my short another day =O

[ClayTrader]

* * $OPXA Video Chart 11-22-16 * *

Link to Video - click here to watch the technical chart video

[beambe]

OPXA Goo ,70

[beambe]

It might fall again ,70

[UP Trend]

Low floater with volume!

[Stefa]

Dilution.

[UP Trend]

In for the squeeze!

[redspinelpinktopaz]

With the volume three times the shares outstanding, the buying has to come from something AWAY from the company. What, who, and where?

[Moto260]

See if we can pull this back up from the gap down this A.M

[Prinz18]

Insider selling at $ 0.55!!!

[NASDAQjack]

No volume under r/g level and reclaim! Looks like an early short trap attempt. Not worth being early on the short side.

[NASDAQjack]

Idea on OPXA and few others for 22 of November https://nasdaqjackblog.wordpress.com/scan/